BioSpace News Archive

Microneedles are used for micro-projections of drugs. Microneedles are the pathways to biological membranes which can create transport pathways of micron dimensions for sampling body fluids, such as for measuring the blood glucose levels in diabetic therapy.

The global life science instrumentation market is projected to reach US$ 90 Bn by 2027, expanding at a single digit CAGR during the forecast period.

Collaboration combines Engitix’s unique ECM platform with Takeda’s expertise in gastroenterology research and development and commercialisation

Partnership Focused In Short Term On COVID-19 Genetic Diagnostics and Solutions, Long Term Collaboration On Partner Diagnostics and Therapeutics

iVeena, a clinical stage biopharmaceutical company with products in development for unmet needs in ophthalmology, announces the successful completion of the Series B preferred stock bridge round.

Achievement of primary efficacy endpoint in 3-arm SUI feasibility study demonstrates significant separation between CMRF treatment arm and inert sham arm

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that Company CEO Dwight Egan will be discussing the Company’s significant growth, profitability, and future objectives at H.C. Wainwright’s 22nd Annual Global Investment Conference on Monday, September 14th at 10:00 ET.

IZI Medical Products, LLC, a leading manufacturer of interventional radiology devices, announces the official launch of its Osteo-Site Vertebral Balloon for vertebral augmentation.

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for serious and orphan diseases, announced that it has been awarded a grant from the Alzheimer’s Association’s Part the Cloud-Gates Partnership Grant Program.

CB2 Insights Inc. (“ CB2 ” or the “ Company ”) (CSE: CBII; OTCQB: CBIIF), will be hosting its Q2 2020 earnings call on Tuesday, September 1 st , 2020 at 9:00 a.m. Eastern Daylight Time (EDT). CB2 will issue a press release and file its interim financial statements and interim Quarterly Management Discussion and Analysis (“MD&A”) for the quarter ended June 30, 2020 (the “Q1 2020 Filings”) after the close of markets on August 31 st , 2020. C